亚盛医药在港交所公告截至2025年6月30日止六个月收益为人民币2.34亿元同比减少71.6%主要是由于截至2024年6

智通财经
Aug 21
亚盛医药在港交所公告截至2025年6月30日止六个月收益为人民币2.34亿元同比减少71.6%主要是由于截至2024年6月30日止六个月产生的知识产权收益导致。亏损净额为人民币5.91亿元上年同期溢利人民币1.63亿元主要是由于上文所述的知识产权收益减少。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10